Seven states with low vaccination rates and high COVID-19 infection rates are using most of the drug that hospitals administer to people who are infected.
Alabama, Florida, Texas, Mississippi, Tennessee, Georgia and Louisiana have used so many monoclonal antibodies that the nation’s supply is getting tight and some patients who might have been treated won’t be.
Tennessee is recommending that doctors and hospitals not give monoclonal antibody treatments to people who have been vaccinated against the coronavirus, but instead to save them to treat people who have chosen not to be vaccinated. As NBC News reports, Tennessee, which has a 44.1% vaccination rate — one of the worst rates in the country — will be a place where “the patients first in line for the monoclonal antibody COVID-19 treatment are likely to be the ones who landed in the emergency room because they did not get vaccinated.”
NBC explains the logic behind the decision:
“What the state is doing is putting the highest risk patients first in line,” Dr. Karen Bloch of Vanderbilt University Medical Center said. “And not having a vaccine does place one at a higher risk of dying from Covid. So, identifying those most at risk makes sense.”
The drug works best if it is administered within 10 days of a person being infected or exposed to the virus. It is generally given to high-risk patients who have heart disease, diabetes or obesity. It has a track record of reducing hospitalizations if the infection is caught early enough.
Dr. E. Turner Overton, co-director of the Alabama Vaccine Research Clinic at the University of Alabama at Birmingham, says monoclonal antibody infusions lower the odds of hospitalization by 70% in high-risk unvaccinated people.
Georgia is another heavy user of monoclonal antibodies, and the state just got word that the federal government is now going to control distribution. Georgia Health News reports:
Michael Purvis, CEO of Candler County Hospital in east Georgia, said his hospital was down to just four doses over the past weekend, then got a resupply of 48 more on Monday.
The hospital normally delivers 100 to 125 doses to patients a week, he said. “I’m not going to get as much,’’ Purvis said.
South Georgia Medical Center last week said that it postponed monoclonal antibody infusion treatments. The Valdosta hospital reported giving more than 100 doses per day. Also last week, Colquitt Regional Medical Center in southwest Georgia temporarily closed its infusion center.
Anna Adams, a Georgia Hospital Association executive, said that “we’ve got hospitals that have had to cancel appointments and shut down their (infusion) sites, waiting for supplies.”
“If people don’t have access to this, their chances of being hospitalized are much greater,’’ she said, adding that some smaller hospitals “have had the busiest sites.’’
The federal government has shipped about two and a half million doses of the drug to 8,000 hospitals and clinics and the U.S. Department of Health and Human Services says 44% of that supply has been used up. In June, health care workers were administering about 10,000 doses a week. It now is being used at a rate of 200,000 a week.
MSNBC published an opinion piece that tries to reconcile the thinking that COVID-19 vaccines are somehow not trustworthy but monoclonal antibodies administered by hospitals are. The piece notes that the drugs “have until recently flown under the radar and once received a high-profile endorsement from former President Donald Trump. And the fact that the drug can be administered after one falls ill makes it compatible with the ruthless individualism championed by the right throughout the pandemic.”
By the way, monoclonal antibodies are about 100 times more expensive than the vaccine that likely would have prevented the need to use them. And, MSNBC reminds us:
Medical experts have cautioned that monoclonal antibodies can’t substitute for the vaccines because they’re not as durable and because they’re effective for only a certain window of time after symptoms appear.
The cost of remote work